Zicam And Cold-EEZE Duel In Cold Duration-Shortening Space
This article was originally published in The Tan Sheet
Executive Summary
Zicam brand sales lead Cold-EEZE among zinc-containing products in the cold duration-shortening space within the broad cold remedies category, though Cold-EEZE products show stronger growth in some sub-categories.
You may also be interested in...
Zicam Creates A Monster With Reanimated Brand
Matrixx aims to make more consumers aware they can shorten the duration of a cold rather than treat the symptoms without affecting how long the cold lasts. New advertising introduces the “Cold Monster” to remind consumers to use Zicam products when they feel the first signs of a “monster of a cold.”
In Brief
Novartis ships Excedrin Migraine; Perrigo will launch mini nicotine lozenges; Matrixx ups offer to buy ProPhase; Merck consolidates HQ in Summit, N.J.; NBTY expects at least 3% sales boost; FDA will hold risk communication meeting; more news In Brief.
GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health
Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.